Table 1.
Clinicopathologic characteristics of studied patients and expression of CDK11 in lipoma and liposarcoma.
| NO (%) | |||||
|---|---|---|---|---|---|
| Gender | |||||
| Male | 23 (46.0) | ||||
| Female | 27 (54.0) | ||||
| Age (years) | |||||
| >=60 | 13 (26.0) | ||||
| <60 | 37 (74.0) | ||||
| Pathology | |||||
| Lipoma | 9 (18.0) | ||||
| Liposarcoma, well differntiated | 18 (36.0) | ||||
| Liposarcoma, myxoid | 15 (30.0) | ||||
| Liposarcoma, dedifferntiated | 5 (10.0) | ||||
| Liposarcoma, pleomorphic | 3 (6.0) | ||||
| Survival (n=56) | |||||
| Alive | 33 (66.0) | ||||
| Dead | 17 (34.0) | ||||
| Expression of CDK11 | |||||
| 0 | 1+ | 2+ | 3+ | 4+ | |
| Lipoma (n=9) | 4(44.4) | 5(55.6) | |||
| Liposarcoma (n=41) | 3(7.3) | 6(14.6) | 8(19.5) | 11(26.8) | 13(31.7) |
Note: 0 (no positive tumor cells); 1+ (<10% positive tumor cells); 2+ (10–25% positive tumor cells); 3+ (26–50% positive tumor cells); 4+ (51–75% positive tumor cells); 5+ (>75% positive tumor cells)